AstraZeneca (AZN) volatility elevated into shares selling off on failed drug trial
AstraZeneca (NYSE: AZN) July call option implied volatility is at 100, August is at 53; compared to its 52-week range of 20 to 57 into a failed drug trial.
AstraZeneca (NYSE: AZN) July call option implied volatility is at 100, August is at 53; compared to its 52-week range of 20 to 57 into a failed drug trial.